SCHEMBL9147679

SCHEMBL9147679

CCCCC(CC)C(C)C=O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CTSK P43235 6/20 0.40
ALDH1A1 P00352 3/20 0.37
CYP3A4 P08684 1/20 0.37
ADH1B P00325 1/20 0.36
ADH1C P00326 1/20 0.36
ADH1A P07327 1/20 0.36
ADH4 P08319 1/20 0.36
ADH7 P40394 1/20 0.36
CA2 P00918 5/20 0.35
MAPK1 P28482 1/20 0.35
CA1 P00915 3/20 0.34
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SLC15A1 P46059 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598223 0.86 TSHR (0.39) TSHRSMN1; SMN2CTSKADH1BADH1C
SCHEMBL28853381 0.82 ADH1B (0.50) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL27260031 0.81 TSHR (0.42) TSHRSMN1; SMN2CTSKADH1BADH1C
SCHEMBL5365130 0.80
SCHEMBL27861734 0.79 TSHR (0.41) TSHRSMN1; SMN2CTSKCYP3A4ADH1B
SCHEMBL28196129 0.79 ALDH1A1 (0.45) TSHRSMN1; SMN2CTSKALDH1A1CYP3A4
SCHEMBL27278114 0.79 TSHR (0.38) TSHRSMN1; SMN2CTSKALDH1A1CYP3A4
SCHEMBL18967347 0.78 ADH1B (0.47) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL25295858 0.77 TSHR (0.52) TSHRSMN1; SMN2CTSKALDH1A1CYP3A4
SCHEMBL28701042 0.77 CA1 (0.44) TSHRSMN1; SMN2CYP3A4ADH1BADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US claimed
EP-3227255-A1 INTERMEDIATES AND PROCESS FOR THE PREPARATION OF SANDALWOOD OIL BUILDING BLOCKS Firmenich SA (CH) 2017-10-11 EP disclosed
WO-2016087179-A1 INTERMEDIATES AND PROCESS FOR THE PREPARATION OF SANDALWOOD OIL BUILDING BLOCKS FIRMENICH SA (CH) 2016-06-09 WO disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5389626-A 3-aryloxmethyl-cephalosporin derivatives, and their medical use SANKYO COMPANY, LIMITED (JP) 1995-02-14 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0363223-A2 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use Sankyo Company Limited (JP) 1990-04-11 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed